Hope4ATRT_Logo_small.png

Tazemetostat: A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma

Summary

Trial Information

Approach

Additional Information

Eligibility

Contact Information